Novelix Pharma.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: INE314I01036
  • NSEID:
  • BSEID: 536565
INR
65.37
-2.32 (-3.43%)
BSENSE

Nov 20

BSE+NSE Vol: 6.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "65.37",
    "chg": -2.32,
    "chgp": "-3.43%",
    "dir": -1,
    "prev_price": "67.69",
    "mcapval": "190.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE314I01036",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "6.28 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4266895",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NovelixPharmace_mojoScore_4266895.png",
        "date": "2026-11-18 10:10:05",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance Amid Margin Expansion",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-reports-very-positive-quarterly-financial-performance-amid-margin-expansion-4262831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NovelixPharmace_fintrenddot_4262831.png",
        "date": "2026-11-16 08:00:08",
        "description": "Novelix Pharmaceuticals Ltd has delivered a very positive financial performance for the quarter ended September 2026, marking a significant improvement in revenue growth and profitability metrics compared to its historical trends. Despite operating within the retailing sector as a micro-cap entity, the company’s recent results demonstrate robust operational efficiency and margin expansion, signalling a favourable shift in its financial trajectory."
      },
      {
        "title": "Novelix Pharmaceuticals Gains 8.34%: Key Drivers Behind This Week’s Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/novelix-pharmaceuticals-gains-834-key-drivers-behind-this-weeks-rally-4262673",
        "imagepath": "",
        "date": "2026-11-15 14:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock opens at Rs.63.24, down 2.20% amid broader market gains</p>\n                    <p><strong>Nov 11:</strong> Sharp rebound with 5.98% gain to Rs.67.02 following positive quarterly results</p>\n                    <p><strong>Nov 12:</strong> Continued rally to Rs.69.12 as valuation shifts to fair from attractive</p>\n                    <p><strong>Nov 13:</strong> Week closes at Rs.70.05, up 1.35% despite Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.64.66</div></div>\n                    <div class=\"stat-item\"><div cla..."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Reports Positive Quarterly Growth Amid Financial Trend Adjustment",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-reports-positive-quarterly-growth-amid-financial-trend-adjustment-4259382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NovelixPharmace_fintrenddot_4259382.png",
        "date": "2026-11-12 11:00:10",
        "description": "Novelix Pharmaceuticals Ltd has demonstrated a positive financial performance in the quarter ended September 2026, marking a shift from a previously very positive trend to a positive one. The company’s net sales surged by 21.8% compared to the previous four-quarter average, while profitability metrics reached record highs, signalling robust operational execution despite a slight moderation in its overall financial trend score."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4249655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NovelixPharmace_valuationdot_4249655.png",
        "date": "2026-11-04 08:00:19",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its valuation parameters shift favourably, moving from fair to attractive territory despite a recent dip in share price. This change comes amid a backdrop of mixed returns relative to the broader Sensex index, prompting investors to reassess the stock’s price attractiveness and growth prospects."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4242099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NovelixPharmace_mojoScore_4242099.png",
        "date": "2026-10-28 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4228245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NovelixPharmace_mojoScore_4228245.png",
        "date": "2026-10-17 10:10:44",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4216009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NovelixPharmace_mojoScore_4216009.png",
        "date": "2026-10-06 10:11:00",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4204720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NovelixPharmace_mojoScore_4204720.png",
        "date": "2026-09-25 10:11:00",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Sep 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 48,
    "sid": "200695",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Opening Of Corporate Office.",
      "datetime": "17-Nov-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2026",
      "details": "Newspaper publication of Results for September 2026 quarter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Supply Agreement",
      "datetime": "13-Nov-2026",
      "details": "Submission of Supply agreement intimation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement Under Regulation 30 (LODR)- Opening Of Corporate Office.

17-Nov-2026 | Source : BSE

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2026 | Source : BSE

Newspaper publication of Results for September 2026 quarter.

Announcement Under Regulation 30 (LODR)- Supply Agreement

13-Nov-2026 | Source : BSE

Submission of Supply agreement intimation.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Novelix Pharmaceuticals Ltd has declared 3% dividend, ex-date: 16 Aug 12

stock-summary
SPLITS

Novelix Pharmaceuticals Ltd has announced 10:1 stock split, ex-date: 04 Oct 10

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available